Millennium Management’s Aethlon Medical AEMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-52
Closed -$16K 6048
2023
Q1
$16K Buy
52
+10
+24% +$3.77K ﹤0.01% 5917
2022
Q4
$9K Buy
+42
New +$15.3K ﹤0.01% 6200
2021
Q2
Sell
-19
Closed -$30K 6456
2021
Q1
$30K Buy
+19
New +$36.6K ﹤0.01% 5804
2018
Q3
Sell
-17
Closed -$256K 3855
2018
Q2
$256K Hold
17
﹤0.01% 3457
2018
Q1
$238K Buy
+17
New +$301K ﹤0.01% 3309
2015
Q4
Sell
-1
Closed -$98K 3370
2015
Q3
$98K Buy
+1
New +$101K ﹤0.01% 3275

Other funds holding AEMD

Millennium Management's AEMD Position: Q2 2023 in Review

Millennium Management sold out of Aethlon Medical (AEMD) in Q2 2023, closing a stake of 52 shares — an estimated $16K sold.

Millennium Management first reported a position in AEMD in Q3 2015 and held it in 6 quarters. The position peaked at $256K in Q2 2018. 22 funds tracked by Wall St. Rank hold AEMD as of Q2 2023.

  • Millennium Management reported no remaining Aethlon Medical position as of Q2 2023 after selling out during the quarter.
  • Millennium Management sold 52 Aethlon Medical shares in Q2 2023, an estimated $16K.
  • Millennium Management first reported a position in Aethlon Medical in Q3 2015 and held it in 6 quarters.
  • Millennium Management's Aethlon Medical position peaked at $256K in Q2 2018.
  • 22 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.